Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2019	Dec. 31, 2018
ASSETS:
Cash and cash equivalents		$ 187.4	$ 25.7
Restricted cash and cash equivalents		330.3	303.6
Restricted securities available for sale	[1]	59.3	58.6
Loans receivable (including $1.4 from affiliates as of December 31, 2016)		7,221.2	6,225.2
Allowance for credit losses		(536.0)	(461.9)
Loans receivable, net		6,685.2	5,763.3
Property and equipment, net		59.7	40.2
Income taxes receivable		66.2	7.9
Other assets		35.1	38.1
Total Assets		7,423.2	6,237.4
Liabilities:
Accounts payable and accrued liabilities		206.4	186.4
Revolving secured line of credit		0.0	171.9
Secured financing		3,339.7	3,092.7
Senior notes		1,187.8	544.4
Other Borrowings	[2]	11.3	11.9
Deferred income taxes, net		322.5	236.7
Income taxes payable		0.2	2.5
Total Liabilities		5,067.9	4,246.5
Shareholders' Equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized, none issued		0.0	0.0
Common stock, $0.01 par value, 80,000,000 shares authorized, 18,352,779 and 18,972,558 shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively		0.2	0.2
Paid-in capital		157.7	154.9
Retained earnings		2,196.6	1,836.1
Accumulated other comprehensive loss		0.8	(0.3)
Total Shareholders' Equity		2,355.3	1,990.9
Total Liabilities and Shareholders' Equity		$ 7,423.2	$ 6,237.4

[1] Measured at fair value on a recurring basis.

[2] Measured at amortized cost with fair value disclosed.